| 臺大學術典藏 |
2020-12-23T05:43:45Z |
Outcomes from out-of-hospital cardiac arrest in Metropolitan Taipei: Does an advanced life support service make a difference?
|
WEN-CHU CHIANG; Ma M.H.-M.; Ma M.H.-M.;Wen-Chu Chiang;Ko P.C.-I.;Huang J.C.-C.;Lin C.-H.;Wang H.-C.;Chang W.-T.;Hwang C.-H.;Wang Y.-C.;Hsiung G.-H.;Lee B.-C.;Chen S.-C.;Chen W.-J.;Lin F.-Y.; Ko P.C.-I.; Huang J.C.-C.; Lin C.-H.; Wang H.-C.; Chang W.-T.; Hwang C.-H.; Wang Y.-C.; Hsiung G.-H.; Lee B.-C.; Chen S.-C.; Chen W.-J.; Lin F.-Y. |
| 國家衛生研究院 |
2011-06-15 |
Outcomes in advanced legg-calve-perthes disease treated with the staheli procedure
|
Chang, JH;Kuo, KN;Huang, SC |
| 國立臺灣大學 |
2011 |
Outcomes in Advanced Legg-Calve-Perthes Disease Treated with the Staheli Procedure
|
張振慧; 郭耿南; 黃世傑; CHANG, JEN-HUEI; KUO, KEN-NAN; HUANG, SHIER-CHIEG |
| 臺大學術典藏 |
2018-09-10T08:28:41Z |
Outcomes in advanced Legg-Calvé-Perthes disease treated with the Staheli procedure
|
Chang, J.-H. Kuo, K.N. Huang, S.-C.; SHIER-CHIEG HUANG |
| 臺大學術典藏 |
2021-08-31T05:26:57Z |
Outcomes in Chronic Hemodynamically Significant Aortic Regurgitation and Limitations of Current Guidelines
|
LI-TAN YANG; Michelena H.I.; Scott C.G.; Enriquez-Sarano M.; Pislaru S.V.; Schaff H.V.; Pellikka P.A. |
| 臺大學術典藏 |
2022-09-20T07:56:53Z |
Outcomes in Chronic Hemodynamically Significant Aortic Regurgitation and Limitations of Current Guidelines
|
LI-TAN YANG; Michelena H.I.; Scott C.G.; Enriquez-Sarano M.; Pislaru S.V.; Schaff H.V.; Pellikka P.A. |
| 臺北醫學大學 |
2014 |
Outcomes in Elder Heart Transplantation Recipients: An Analysis of Taiwan Organ Registry and Sharing Center Registry
|
Lee, K.;Lin, C.;Tsai, Y.;Lee, C.;Hsu, P.;Lin, Y.;Lee, W.;Lin, F.;Lai, C.;Tsai, C. |
| 臺北醫學大學 |
2014 |
Outcomes in Elder Heart Transplantation Recipients: An Analysis of Taiwan Organ Registry and Sharing Center Registry.
|
Lee, K.;Lin, C.;Tsai, Y.;Lee, C.;Hsu, P.;Lin, Y.;Lee, W.;Lin, F.;Lai, C.;Tsai, C. |
| 國立臺灣大學 |
2009 |
Outcomes in Neonates with Pulmonary Atresia and Intact Ventricular Septum Underwent Pulmonary Valvulotomy and Valvuloplasty Using a Flexible 2- French Radiofrequency Catheter
|
李孟倫; 曹龍彥; 邱漢堯; 陳明; 邱英世; LEE, MENG-LUEN; TSAO, LON-YEN; CHIU, HAN-YAO; CHEN, MING; CHIU, ING-SH |
| 臺大學術典藏 |
2018-09-10T07:46:02Z |
Outcomes in neonates with pulmonary atresia and intact ventricular septum underwent pulmonary valvulotomy and valvuloplasty using a flexible 2-french radiofrequency catheter
|
Lee, Meng-Luen;Tsao, Lon-Yen;Chiu, Han-Yao;Chen, Ming;Chiu, Ing-Sh; LEE, MENG-LUEN;TSAO, LON-YEN;CHIU, HAN-YAO;CHEN, MING;CHIU, ING-SH; 李孟倫;曹龍彥;邱漢堯;陳明;邱英世; MING CHEN; ING-SH CHIU; LEE, MENG-LUEN; TSAO, LON-YEN; CHIU, HAN-YAO; CHEN, MING; CHIU, ING-SH |
| 臺大學術典藏 |
2019-03-04T08:04:19Z |
Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study
|
CHONG-JEN YU; CHAO-CHI HO; WEI-YU LIAO; Lee, Jih Hsing; Tsai, Tzu Hsiu; KANG-YI SU; MIN-SHU HSIEH; YIH-LEONG CHANG; Bai, Ya Ying; Huang, Derek De Rui; Thress, Kenneth S.; CHIH-HSIN YANG; JIN-YUAN SHIH; Lin, Chia Chi; Thress, Kenneth S.;Huang, Derek De Rui;Bai, Ya Ying;Lee, Jih Hsing;Lin, Chia Chi;CHIH-HSIN YANG;YIH-LEONG CHANG;MIN-SHU HSIEH;KANG-YI SU;Tsai, Tzu Hsiu;WEI-YU LIAO;CHAO-CHI HO;CHONG-JEN YU;JIN-YUAN SHIH |
| 臺大學術典藏 |
2020-03-05T08:04:01Z |
Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study
|
Lin C.-C.; Shih J.-Y.; Yu C.-J.; Ho C.-C.; Liao W.-Y.; Lee J.-H.; Tsai T.-H.; Su K.-Y.; MIN-SHU HSIEH; Chang Y.-L.; Bai Y.-Y.; Huang D.D.-R.; Thress K.S.; Yang J.C.-H.; Lin C.-C.;Shih J.-Y.;Yu C.-J.;Ho C.-C.;Liao W.-Y.;Lee J.-H.;Tsai T.-H.;Su K.-Y.;Min-Shu Hsieh;Chang Y.-L.;Bai Y.-Y.;Huang D.D.-R.;Thress K.S.;Yang J.C.-H. |
| 臺大學術典藏 |
2020-03-06T05:26:03Z |
Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study
|
Lin C.-C.; Shih J.-Y.; Yu C.-J.; Ho C.-C.; Liao W.-Y.; Lee J.-H.; Tsai T.-H.; Su K.-Y.; Hsieh M.-S.; YIH-LEONG CHANG; Bai Y.-Y.; Huang D.D.-R.; Thress K.S.; Yang J.C.-H. |
| 臺大學術典藏 |
2020-03-07T06:56:12Z |
Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study
|
Lin C.-C.; Shih J.-Y.; Yu C.-J.; Ho C.-C.; Liao W.-Y.; Lee J.-H.; Tsai T.-H.; Su K.-Y.; Hsieh M.-S.; YIH-LEONG CHANG; Bai Y.-Y.; Huang D.D.-R.; Thress K.S.; Yang J.C.-H.; Lin C.-C.;Shih J.-Y.;Yu C.-J.;Ho C.-C.;Liao W.-Y.;Lee J.-H.;Tsai T.-H.;Su K.-Y.;Hsieh M.-S.;Yih-Leong Chang;Bai Y.-Y.;Huang D.D.-R.;Thress K.S.;Yang J.C.-H. |
| 臺大學術典藏 |
2020-05-25T07:35:13Z |
Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study
|
Chia-Chi Lin; Shih J.-Y; Yu C.-J; Ho C.-C; Liao W.-Y; Lee J.-H; Tsai T.-H; Su K.-Y; Hsieh M.-S; Chang Y.-L; Bai Y.-Y; Huang D.D.-R; Thress K.S; Yang J.C.-H. |
| 臺大學術典藏 |
2020-05-26T09:26:31Z |
Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study
|
Chih-Hsin Yang;Thress K.S;Huang D.D.-R;Bai Y.-Y;Chang Y.-L;Hsieh M.-S;Su K.-Y;Tsai T.-H;Lee J.-H;Liao W.-Y;Ho C.-C;Yu C.-J;Shih J.-Y;Lin C.-C; Lin C.-C; Shih J.-Y; Yu C.-J; Ho C.-C; Liao W.-Y; Lee J.-H; Tsai T.-H; Su K.-Y; Hsieh M.-S; Chang Y.-L; Bai Y.-Y; Huang D.D.-R; Thress K.S; CHIH-HSIN YANG |
| 臺大學術典藏 |
2020-06-30T08:09:56Z |
Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study
|
Lin C.-C.;Shih J.-Y.;Yu C.-J.;Ho C.-C.;Liao W.-Y.;Lee J.-H.;Tsai T.-H.;Kang-Yi Su;Hsieh M.-S.;Chang Y.-L.;Bai Y.-Y.;Huang D.D.-R.;Thress K.S.;Yang J.C.-H.; Lin C.-C.; Shih J.-Y.; Yu C.-J.; Ho C.-C.; Liao W.-Y.; Lee J.-H.; Tsai T.-H.; KANG-YI SU; Hsieh M.-S.; Chang Y.-L.; Bai Y.-Y.; Huang D.D.-R.; Thress K.S.; Yang J.C.-H. |
| 臺大學術典藏 |
2018 |
Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study
|
Yang J.C.-H.; Thress K.S.; Huang D.D.-R.; Bai Y.-Y.; Chang Y.-L.; Hsieh M.-S.; Su K.-Y.; Lin C.-C.;Shih J.-Y.;Yu C.-J.;Ho C.-C.;Wei-Yu Liao;Lee J.-H.;Tsai T.-H.;Su K.-Y.;Hsieh M.-S.;Chang Y.-L.;Bai Y.-Y.;Huang D.D.-R.;Thress K.S.;Yang J.C.-H.; Lin C.-C.; Shih J.-Y.; Yu C.-J.; Ho C.-C.; WEI-YU LIAO; Lee J.-H.; Tsai T.-H. |
| 臺大學術典藏 |
2020-07-21T06:25:17Z |
Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study
|
Yang J.C.-H.; Thress K.S.; Huang D.D.-R.; Lin C.-C.;Shih J.-Y.;Yu C.-J.;Ho C.-C.;Liao W.-Y.;Lee J.-H.;Tzu-Hsiu Tsai;Su K.-Y.;Hsieh M.-S.;Chang Y.-L.;Bai Y.-Y.;Huang D.D.-R.;Thress K.S.;Yang J.C.-H.; Lin C.-C.; Shih J.-Y.; Yu C.-J.; Ho C.-C.; Liao W.-Y.; Lee J.-H.; TZU-HSIU TSAI; Su K.-Y.; Hsieh M.-S.; Chang Y.-L.; Bai Y.-Y. |
| 臺大學術典藏 |
2020-07-21T06:46:19Z |
Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study
|
Yu C.-J.; CHAO-CHI HO; Liao W.-Y.; Lee J.-H.; Tsai T.-H.; Su K.-Y.; Hsieh M.-S.; Chang Y.-L.; Bai Y.-Y.; Huang D.D.-R.; Thress K.S.; Yang J.C.-H.; Lin C.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2020-08-12T02:50:40Z |
Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study
|
Lin C.-C.;Shih J.-Y.;Yu C.-J.;Chao-Chi Ho;Liao W.-Y.;Lee J.-H.;Tsai T.-H.;Su K.-Y.;Hsieh M.-S.;Chang Y.-L.;Bai Y.-Y.;Huang D.D.-R.;Thress K.S.;Yang J.C.-H.; Lin C.-C.; Shih J.-Y.; Yu C.-J.; CHAO-CHI HO; Liao W.-Y.; Lee J.-H.; Tsai T.-H.; Su K.-Y.; Hsieh M.-S.; Chang Y.-L.; Bai Y.-Y.; Huang D.D.-R.; Thress K.S.; Yang J.C.-H. |
| 臺大學術典藏 |
2020-08-13T06:33:33Z |
Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study
|
Yang J.C.-H.; Thress K.S.; Huang D.D.-R.; Bai Y.-Y.; Chang Y.-L.; Hsieh M.-S.; Su K.-Y.; Tsai T.-H.; Lee J.-H.; Liao W.-Y.; Ho C.-C.; Lin C.-C.; JIN-YUAN SHIH; Yu C.-J.; Lin C.-C.;Jin-Yuan Shih;Yu C.-J.;Ho C.-C.;Liao W.-Y.;Lee J.-H.;Tsai T.-H.;Su K.-Y.;Hsieh M.-S.;Chang Y.-L.;Bai Y.-Y.;Huang D.D.-R.;Thress K.S.;Yang J.C.-H. |
| 臺大學術典藏 |
2021-07-13T06:04:33Z |
Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study
|
Lin C.-C.; Shih J.-Y.; Yu C.-J.; Ho C.-C.; Liao W.-Y.; LEE JIH-HSIANG; Tsai T.-H.; Su K.-Y.; Hsieh M.-S.; Chang Y.-L.; Bai Y.-Y.; Huang D.D.-R.; Thress K.S.; Yang J.C.-H. |
| 臺大學術典藏 |
2022-02-21T03:52:35Z |
Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study
|
Lin C.-C.; Shih J.-Y.; Yu C.-J.; Ho C.-C.; Liao W.-Y.; JIH-HSIANG LEE; Tsai T.-H.; Su K.-Y.; Hsieh M.-S.; Chang Y.-L.; Bai Y.-Y.; Huang D.D.-R.; Thress K.S.; Yang J.C.-H. |
| 臺大學術典藏 |
2022-06-27T07:00:03Z |
Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study
|
Lin C.-C.; Shih J.-Y.; CHONG-JEN YU; Ho C.-C.; Liao W.-Y.; Lee J.-H.; Tsai T.-H.; Su K.-Y.; Hsieh M.-S.; Chang Y.-L.; Bai Y.-Y.; Huang D.D.-R.; Thress K.S.; Yang J.C.-H. |
